EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs

Danielle M Zwueste, Karen M Vernau, William Vernau, Bruno H Pypendop, Heather K Knych, Carlos A Rodrigues, Amir Kol, Maria Questa, Peter J Dickinson iD

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Danielle M Zwueste und 8 weiteren Autor:innen. Beteiligte Einrichtung: William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Arabinofuranosylcytosine Triphosphate, Prodrugs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Center for Companion Animal Health, University of California, Davis, Holliday Neurology Resident Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytosine arabinoside (Ara-C) is a nucleoside analog prodrug utilized for immunomodulatory effects mediated by its active metabolite Ara-CTP. Optimal dosing protocols for immunomodulation in dogs have not been defined. Cytarabine ocfosfate (CO) is a lipophilic prodrug of Ara-C that can be administered PO and provides prolonged serum concentrations of Ara-C.

Objectives

Provide pharmacokinetic data for orally administered CO and determine accumulation and functional consequences of Ara-CTP within peripheral blood leukocytes. Animals Three healthy female hound dogs and 1 healthy male Beagle.

Methods

Prospective study. Dogs received 200 mg/m2 of CO PO q24h for 7 doses. Serum and cerebrospinal fluid (CSF) CO and Ara-C concentrations were measured by liquid chromatography-tandem mass spectroscopy (LC-MS/MS). Complete blood counts, flow cytometry, and leukocyte activation assays were done up to 21 days. Incorporation of Ara-CTP within leukocyte DNA was determined by LC-MS/MS.

Results

Maximum serum concentration (Cmax) for Ara-C was 456.1-724.0 ng/mL (1.88-2.98 μM) and terminal half-life was 23.3 to 29.4 hours. Cerebrospinal fluid: serum Ara-C ratios ranged from 0.54 to 1.2. Peripheral blood lymphocyte concentrations remained within the reference range, but proliferation rates poststimulation were decreased at 6 days. Incorporation of Ara-CTP was not saturated and remained >25% of peak concentration at 13 days. Conclusions and Clinical Importance Oral CO may produce prolonged serum Ara-C half-lives at concentrations sufficient to induce functional changes in peripheral leukocytes and is associated with prolonged retention of DNA-incorporated Ara-CTP. Application of functional and active metabolite assessment is feasible and may provide more relevant data to determine optimal dosing regimens for Ara-C-based treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arabinofuranosylcytosine TriphosphateProdrugsFemaleMaleDogsAnimalsChromatography, LiquidProspective StudiesTandem Mass SpectrometryLeukocytesBiomarkersCytarabineDNAArabinonucleotidesCytidine Monophosphate

Stichwörter der Autor:innen

Ara-CAra-CTPCytosarHPLCcanineprodrug

Substanzen

Arabinofuranosylcytosine TriphosphateProdrugsBiomarkersCytarabineDNA1-arabinofuranosylcytosine-5'-stearylphosphateArabinonucleotidesCytidine Monophosphate

Autor:innen und Institutionen

  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, California, USA.
  • Department of Surgical and Radiological Sciences, University of California Davis, Davis, California, USA.
  • Department of Pathology, Microbiology and Immunology, University of California Davis, Davis, California, USA.
  • K.L. Maddy Equine Analytic Chemistry Laboratory, UC Davis, Davis, California, USA.

ORCID-Profile: Peter J Dickinson

Förderung

  • Center for Companion Animal Health, University of California, Davis
  • Holliday Neurology Resident Research Grant

Zitieren

APA

Zwueste, D. M., Vernau, K. M., Vernau, W., Pypendop, B. H., Knych, H. K., Rodrigues, C. A., Kol, A., Questa, M., & Dickinson, P. J. (2023). Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16842

Vancouver

Zwueste DM, Vernau KM, Vernau W, Pypendop BH, Knych HK, Rodrigues CA, et al. Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16842

BibTeX
@article{Zwueste2023,
  author = {Zwueste, Danielle M and Vernau, Karen M and Vernau, William and Pypendop, Bruno H and Knych, Heather K and Rodrigues, Carlos A and Kol, Amir and Questa, Maria and Dickinson, Peter J},
  title = {Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16842}
}
Kostenlos starten →